Xingye Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xingye Wu has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Jiaqin Jiang
Department of Endocrinology and Metabolism, Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, People’s Republic of China
2 shared publications- Ruibing Qi
Department of Endocrinology and Metabolism, Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, People’s Republic of China
2 shared publications Bing Chen
Department of Endocrinology, Wuming Hospital of Guangxi Medical University, Nanning, 530199, People's Republic of China
1 shared publication- Jiacheng Mo
Information Network Management Center, the Health Governance and Smart Medical Engineering Research Center of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People’s Republic of China
1 shared publication Jingming Yu
Department of Endocrinology and Metabolism, Guangxi Academy of Medical Sciences and the People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, 530021, People's Republic of China
1 shared publicationJinming Yu
Department of Endocrinology and Metabolism, Guangxi Academy of Medical Sciences and the People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, People’s Republic of China
1 shared publication
Latest Publications
- Open Access
- 1 October 2025
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 18, 3705-3716
Correlation Between the Controlled Attenuation Parameter and the Prevalence of T2DM in Southern China: A Retrospective Cross-Sectional Study
Objective: To explore the relationship between controlled attenuation parameters (CAP) of the liver and the risk of type 2 diabetes mellitus (T2DM), and to determine the optimal cutoff value of CAP for predicting T2DM. Methods: This study employed a cross-sectional study design, enrolling 7035 participants. CAP values were measured using hepatic transient elastography, and participants were categorized into low (≤ 231 dB/m), middle (232~269 dB/m), and high (≥ 270 dB/m) groups. Multivariate logistic regression analysis was used to assess the association between CAP and T2DM, and the optimal cutoff value was determined using receiver operating characteristic (ROC) curves. Results: After adjusting for potential confounders, participants in the high-CAP group had a significantly greater risk of developing T2DM than did those in the low-CAP group (OR=1.545; 95% CI=1.263– 1.890; p< 0.001). Stratified analyses revealed that compared with a low CAP, a 1.0-increased CAP was associated with a 0.852-fold increased T2DM risk in people aged < 55 years (OR=1.852; 95% CI=1.405– 2.441; p< 0.001) and a 0.6-fold increased T2DM risk in overweight patients (BMI≥ 24 kg/m2) (OR=1.600; 95% CI=1.127– 2.271; p=0.009). ROC analysis revealed an optimal CAP cutoff value of 246.5 dB/m for T2DM prediction, with an area under the curve of 0.569 (specificity=48.2%, sensitivity=64.2%). Conclusion: CAP levels are associated with a dose-response relationship with the risk of T2DM, particularly in younger and overweight populations. Although CAP has limited predictive value on its own, it can be used as an auxiliary indicator for T2DM risk screening.
- 1 October 2025
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 18, 3705-3716
Open AccessCorrelation Between the Controlled Attenuation Parameter and the Prevalence of T2DM in Southern China: A Retrospective Cross-Sectional Study
Objective: To explore the relationship between controlled attenuation parameters (CAP) of the liver and the risk of type 2 diabetes mellitus (T2DM), and to determine the optimal cutoff value of CAP for predicting T2DM. Methods: This study employed a cross-sectional study design, enrolling 7035 participants. CAP values were measured using hepatic transient elastography, and participants were categorized into low (≤ 231 dB/m), middle (232~269 dB/m), and high (≥ 270 dB/m) groups. Multivariate logistic regression analysis was used to assess the association between CAP and T2DM, and the optimal cutoff value was determined using receiver operating characteristic (ROC) curves. Results: After adjusting for potential confounders, participants in the high-CAP group had a significantly greater risk of developing T2DM than did those in the low-CAP group (OR=1.545; 95% CI=1.263– 1.890; p< 0.001). Stratified analyses revealed that compared with a low CAP, a 1.0-increased CAP was associated with a 0.852-fold increased T2DM risk in people aged < 55 years (OR=1.852; 95% CI=1.405– 2.441; p< 0.001) and a 0.6-fold increased T2DM risk in overweight patients (BMI≥ 24 kg/m2) (OR=1.600; 95% CI=1.127– 2.271; p=0.009). ROC analysis revealed an optimal CAP cutoff value of 246.5 dB/m for T2DM prediction, with an area under the curve of 0.569 (specificity=48.2%, sensitivity=64.2%). Conclusion: CAP levels are associated with a dose-response relationship with the risk of T2DM, particularly in younger and overweight populations. Although CAP has limited predictive value on its own, it can be used as an auxiliary indicator for T2DM risk screening.
- Open Access
- 1 December 2024
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 17, 4777-4787
Correlation Between Thyroid Hormone and Controlled Attenuation Parameters: A Cross-Sectional Population-Based Study
The aim of the present study was to investigate how thyroid hormone levels are related to controlled attenuation parameters (CAP), which may provide insights for understanding the role of these factors in hepatic steatosis. A total of 3461 participants who underwent CAP diagnosis between 2018 and 2023 were included. The associations between thyroid hormone levels and CAP were evaluated through multiple linear regression, restricted cubic splines (RCS) and threshold effect analyses. Multiple linear regression analysis revealed an inverse relationship between free thyroxine (FT4) and CAP, with a coefficient of −0.855 and a confidence interval of −1.297 to −0.412. The negative connection in a subset examination persisted in males [−0.729 (−1.295, −0.162)] and females [−1.234 (−1.996, −0.473)]. A strong correlation was found between free 3,5,3′-triiodothyronine (FT3) and CAP, with values of 2.182 (1.154, 3.211). Further analysis was conducted on both male [1.626 (0.188, 3.065)] and female [2.835 (1.137, 4.533)] subgroups. In the severe liver steatosis group, there was a significant negative correlation between FT3 and CAP based on the subgroup analysis stratified by the level of liver steatosis [−3.804 (−6.711, −0.898)]. The RCS analysis showed a nonlinear association between FT4 and CAP, with a turning point at 11.14 pmol/L. There was a significant linear and nonlinear relationship between FT4, FT3 and CAP. Thyroid hormones could have a significant impact on liver steatosis, offering fresh perspectives on how to prevent and treat this condition.
- 1 December 2024
- Published by Taylor & Francis in Diabetes, Metabolic Syndrome and Obesity
- Vol. ume 17, 4777-4787
Open AccessCorrelation Between Thyroid Hormone and Controlled Attenuation Parameters: A Cross-Sectional Population-Based Study
The aim of the present study was to investigate how thyroid hormone levels are related to controlled attenuation parameters (CAP), which may provide insights for understanding the role of these factors in hepatic steatosis. A total of 3461 participants who underwent CAP diagnosis between 2018 and 2023 were included. The associations between thyroid hormone levels and CAP were evaluated through multiple linear regression, restricted cubic splines (RCS) and threshold effect analyses. Multiple linear regression analysis revealed an inverse relationship between free thyroxine (FT4) and CAP, with a coefficient of −0.855 and a confidence interval of −1.297 to −0.412. The negative connection in a subset examination persisted in males [−0.729 (−1.295, −0.162)] and females [−1.234 (−1.996, −0.473)]. A strong correlation was found between free 3,5,3′-triiodothyronine (FT3) and CAP, with values of 2.182 (1.154, 3.211). Further analysis was conducted on both male [1.626 (0.188, 3.065)] and female [2.835 (1.137, 4.533)] subgroups. In the severe liver steatosis group, there was a significant negative correlation between FT3 and CAP based on the subgroup analysis stratified by the level of liver steatosis [−3.804 (−6.711, −0.898)]. The RCS analysis showed a nonlinear association between FT4 and CAP, with a turning point at 11.14 pmol/L. There was a significant linear and nonlinear relationship between FT4, FT3 and CAP. Thyroid hormones could have a significant impact on liver steatosis, offering fresh perspectives on how to prevent and treat this condition.